These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 25259702

  • 1. Long-term exposure to tenofovir continuously decrease renal function in HIV-1-infected patients with low body weight: results from 10 years of follow-up.
    Nishijima T, Kawasaki Y, Tanaka N, Mizushima D, Aoki T, Watanabe K, Kinai E, Honda H, Yazaki H, Tanuma J, Tsukada K, Teruya K, Kikuchi Y, Gatanaga H, Oka S.
    AIDS; 2014 Aug 24; 28(13):1903-10. PubMed ID: 25259702
    [Abstract] [Full Text] [Related]

  • 2. Effect of Tenofovir Disoproxil Fumarate on Incidence of Chronic Kidney Disease and Rate of Estimated Glomerular Filtration Rate Decrement in HIV-1-Infected Treatment-Naïve Asian Patients: Results from 12-Year Observational Cohort.
    Suzuki S, Nishijima T, Kawasaki Y, Kurosawa T, Mutoh Y, Kikuchi Y, Gatanaga H, Oka S.
    AIDS Patient Care STDS; 2017 Mar 24; 31(3):105-112. PubMed ID: 28282247
    [Abstract] [Full Text] [Related]

  • 3. Renal function and incidence of chronic kidney disease in HIV patients: a Danish cohort study.
    Rasch MG, Engsig FN, Feldt-Rasmussen B, Kirk O, Kronborg G, Pedersen C, Gerstoft J, Obel N.
    Scand J Infect Dis; 2012 Sep 24; 44(9):689-96. PubMed ID: 22680981
    [Abstract] [Full Text] [Related]

  • 4. Effect of baseline renal function on tenofovir-containing antiretroviral therapy outcomes in Zambia.
    Mulenga L, Musonda P, Mwango A, Vinikoor MJ, Davies MA, Mweemba A, Calmy A, Stringer JS, Keiser O, Chi BH, Wandeler G, IeDEA-Southern Africa.
    Clin Infect Dis; 2014 May 24; 58(10):1473-80. PubMed ID: 24585558
    [Abstract] [Full Text] [Related]

  • 5. Changes in the renal function after tenofovir-containing antiretroviral therapy initiation in a Senegalese cohort (ANRS 1215).
    De Beaudrap P, Diallo MB, Landman R, Guèye NF, Ndiaye I, Diouf A, Kane CT, Etard JF, Girard PM, Sow PS, Delaporte E, ANRS 1215 Study Group.
    AIDS Res Hum Retroviruses; 2010 Nov 24; 26(11):1221-7. PubMed ID: 20854202
    [Abstract] [Full Text] [Related]

  • 6. Renal impairment in HIV-infected patients initiating tenofovir-containing antiretroviral therapy regimens in a Primary Healthcare Setting in South Africa.
    Kamkuemah M, Kaplan R, Bekker LG, Little F, Myer L.
    Trop Med Int Health; 2015 Apr 24; 20(4):518-26. PubMed ID: 25442109
    [Abstract] [Full Text] [Related]

  • 7. Incidence and risk factors for tenofovir-associated renal function decline among Thai HIV-infected patients with low-body weight.
    Chaisiri K, Bowonwatanuwong C, Kasettratat N, Kiertiburanakul S.
    Curr HIV Res; 2010 Oct 24; 8(7):504-9. PubMed ID: 21073439
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Incomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposure.
    Jose S, Hamzah L, Campbell LJ, Hill T, Fisher M, Leen C, Gilson R, Walsh J, Nelson M, Hay P, Johnson M, Chadwick D, Nitsch D, Jones R, Sabin CA, Post FA, UK Collaborative HIV Cohort Study Steering Committee.
    J Infect Dis; 2014 Aug 01; 210(3):363-73. PubMed ID: 24585896
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Renal function in patients with preexisting renal disease receiving tenofovir-containing highly active antiretroviral therapy in the HIV outpatient study.
    Young B, Buchacz K, Moorman A, Wood KC, Brooks JT, HIV Outpatient Study (HOPS) Investigators.
    AIDS Patient Care STDS; 2009 Aug 01; 23(8):589-92. PubMed ID: 19591609
    [Abstract] [Full Text] [Related]

  • 15. Changes in glomerular kidney function among HIV-1-uninfected men and women receiving emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis: a randomized clinical trial.
    Mugwanya KK, Wyatt C, Celum C, Donnell D, Mugo NR, Tappero J, Kiarie J, Ronald A, Baeten JM, Partners PrEP Study Team.
    JAMA Intern Med; 2015 Feb 01; 175(2):246-54. PubMed ID: 25531343
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Impact of a tenofovir disoproxil fumarate plus ritonavir-boosted protease inhibitor-based regimen on renal function in HIV-infected individuals: a prospective, multicenter study.
    Cao Y, Han Y, Xie J, Cui Q, Zhang L, Li Y, Li Y, Song X, Zhu T, Li T.
    BMC Infect Dis; 2013 Jul 01; 13():301. PubMed ID: 23815472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.